Balance Sheet: Assets
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Elevance Health Inc. pages available for free this week:
- Income Statement
- Cash Flow Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Net Profit Margin since 2005
- Current Ratio since 2005
- Price to Sales (P/S) since 2005
- Analysis of Revenues
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Elevance Health Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Elevance Health Inc., consolidated balance sheet: assets
US$ in millions
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
Total assets experienced consistent growth over the five-year period, increasing from US$97.46 billion in 2021 to US$121.49 billion in 2025. This growth was driven by increases in both current and noncurrent assets. A notable acceleration in asset growth occurred between 2023 and 2025.
- Current Assets
- Current assets demonstrated an overall upward trend, rising from US$51.12 billion in 2021 to US$63.00 billion in 2025. While generally increasing, a slight dip was observed in 2024, before resuming growth in the final year. The largest component of current assets is consistently premium receivables, which increased steadily throughout the period, reaching US$10.07 billion in 2025. Cash and cash equivalents also showed growth, particularly between 2021 and 2022, and again between 2023 and 2025. Other receivables and other current assets also contributed to the overall increase in current assets.
- Noncurrent Assets
- Noncurrent assets also exhibited consistent growth, increasing from US$46.34 billion in 2021 to US$58.49 billion in 2025. The most significant component of noncurrent assets is goodwill, which increased from US$24.23 billion to US$28.34 billion over the period. Other intangible assets also represent a substantial portion of noncurrent assets, with a notable increase between 2023 and 2024, followed by a slight decrease in 2025. Long-term investments experienced significant growth, nearly doubling from US$5.86 billion in 2021 to US$11.96 billion in 2025. Property and equipment, net, showed modest, consistent growth.
- Investments
- The composition of investments shifted over the period. While fixed maturity securities remained relatively stable overall, with fluctuations between years, equity securities experienced a significant decline from 2021 to 2023 before a partial recovery. Other invested assets demonstrated consistent growth, contributing to the overall increase in long-term investments.
- Assets Held for Sale
- Assets held for sale were not present in the earlier years but appeared in 2024 at US$490 million, then disappeared in 2025. This suggests a potential divestiture or restructuring activity during that year.
In summary, the asset base expanded consistently throughout the observed period, driven by growth in both current and noncurrent asset categories. The increases in goodwill and long-term investments were particularly noteworthy, indicating potential strategic acquisitions or investment activities. The temporary presence of assets held for sale in 2024 suggests possible portfolio adjustments.